# Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

> **NCT06386445** · — · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 500 (estimated)

## Conditions studied

- Stem Cell Transplant Complications
- Acute Graft Versus Host Disease
- Acute Kidney Injury
- Major Adverse Cardiac Events

## Interventions

- **OTHER:** Serum metabolomics sequencing

## Key facts

- **NCT ID:** NCT06386445
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386445, "Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06386445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*